Exoskeletons in Poland

The exoskeleton market in 2026: what we actually know

Our catalogue currently lists nine exoskeletons, and eight of them are on sale (the ninth, Sarcos Guardian XO, has been withdrawn). Rehabilitation and medical designs dominate: EksoNR, Atalante X, LokomatPro, ReWalk Personal, Ekso Indego Personal, ReStore Exo-Suit, HAL and the newest, Eve. The only strictly industrial exoskeleton here is Sarcos Guardian XO.

One inconvenient fact needs saying up front: none of these nine models has a public price in our listings, and for none have we confirmed official availability in Poland. For HAL and Guardian XO we know explicitly that they are not in the Polish offer; for the rest there is simply no confirmation. Manufacturers such as Ekso Bionics sell to clinics on individual quotes, and Cyberdyne offers HAL mainly on lease in Japan. So instead of an imaginary "average price" we give what is documented and mark the gaps clearly.

Scale differs widely. Hocoma claims more than a thousand LokomatPro installations and about 70 clinical studies, while Wandercraft reports more than 150 customers worldwide. The latest launch is Eve: since 17 September 2026 the exoskeleton has been sold commercially in the US, on prescription only after clinical assessment.

For the reader this means a simple rule: the figures in this overview describe the product and its history, not an offer you can order in Poland straight away. Before you start comparing models, decide whether you are interested in equipment for a facility, a private person or a workplace. The answer determines whom to ask for a price, who will carry out the qualification and which documents you will need at purchase.

Types of exoskeletons: three different worlds

Stationary gait-training robots. According to the manufacturer, LokomatPro weighs about a tonne and stays in the therapy room: the patient hangs in a harness above a treadmill while the robot guides the legs. It is the classic hospital solution, not a wearable device.

Mobile rehabilitation exoskeletons. EksoNR (about 25 kg, FDA-cleared) and Atalante X (about 80 kg, self-balancing, no crutches) are used for therapy supervised by a physiotherapist. Indications include stroke, spinal cord injury, traumatic brain injury and multiple sclerosis.

Personal exoskeletons. ReWalk Personal (ReWalk 7), Indego Personal and Eve are meant to let users move outside the clinic, at home or in town. Indego Personal weighs about 14 kg. Since April 2024 it has been reimbursed by Medicare in the US, but that describes the American market, not the Polish one.

Soft and bioelectric systems. ReStore (about 5 kg) is a soft exosuit for gait after stroke, while HAL reads muscle signals from the skin surface and assists movement on that basis.

Industrial. According to its maker, Sarcos Guardian XO lifted up to 90.7 kg, weighed 113 kg and was offered only as a lease service. Production ended after the company was renamed Palladyne AI. Polish logistics is now trialling lighter passive and semi-active systems, for example from the German maker German Bionic, but they are not yet in our catalogue.

What to look for when buying: six criteria

1. Is it a medical device at all. An exoskeleton for patient therapy needs medical certification and, in the United States, FDA clearance, as with EksoNR. Industrial use has no such requirement, but occupational safety rules apply. Start by deciding which side of that line you are on.

2. Clinical indication. Equipment for a high spinal injury is chosen differently from equipment for stroke. ReStore Exo-Suit targets gait rehabilitation after stroke, and ReWalk Personal targets everyday mobility after spinal cord injury. Fit to the diagnosis matters more than the number of features in the brochure.

3. Weight and ergonomics. The gap between 5 kg (ReStore Exo-Suit), 14 kg (Ekso Indego Personal) and 80 kg (Atalante X) translates into transport, donning and handling. In industry the time to put it on counts too: a device that takes a dozen minutes to don is rarely used every day.

4. Operating time and shift planning. According to its maker, Atalante X is meant to work more than eight hours a day, which matters for a centre planning many sessions. Polish trade publications put the battery life of a typical rehabilitation system at 2-4 hours.

5. Service, training and staff certification. As described in Polish sources, a therapist must complete the manufacturer's courses (about 3.5 days basic and 2.5 days advanced). Ask who provides service in Poland and how long parts replacement takes.

6. Financial model. HAL is mostly leased, Sarcos Guardian XO was a service (Robot-as-a-Service), and LokomatPro is a hospital investment. Compare total cost, not the device price.

Price classes: honest about what we do not know

We will not publish a table of model prices because we do not have them documented. Polish trade publications indicate that a mobile rehabilitation exoskeleton costs from about PLN 390,000-450,000 (≈ EUR 89,210–102,940) for a basic version, with extended variants reaching about PLN 950,000 (≈ EUR 217,310). That is an indicative range for the whole segment, not any single maker's offer. A single commercial session at a Polish centre costs PLN 200-350 (≈ EUR 46–80), and a physiotherapy qualification about PLN 150 (≈ EUR 34).

On that basis three classes can be distinguished. The most expensive are stationary hospital systems and advanced clinical exoskeletons (LokomatPro, Atalante X, EksoNR). The middle class is personal devices on prescription (ReWalk Personal, Ekso Indego Personal, Eve). The lightest and least documented on price is the class of soft and bioelectric systems (ReStore Exo-Suit, HAL). This is a split by purpose, not by confirmed amounts.

Funding and reimbursement in Poland

Our listings contain no grant programme aimed directly at exoskeletons, so we will not invent one. A medical facility usually funds the purchase from its own budget, EU funds or dedicated funds. A company buying industrial exoskeletons can check whether the expense fits the “Poland's Robotization Tax Relief”. The relief covers "industrial robots" under a narrow statutory definition, and we do not decide whether an exoskeleton meets it. Ask a tax adviser. A general overview of programmes is in the funding section, and in “Exoskeletons in Rehabilitation and Industry” we described the rehabilitation market in Poland itself.

Three purchasing scenarios

A neurological rehabilitation centre. A facility that wants to run gait training after stroke or spinal injury chooses between a stationary system and a mobile exoskeleton. LokomatPro has the longest installation history, but it occupies a room and guides the patient over a treadmill. EksoNR and Atalante X allow practising gait over the floor, which is closer to the patient's everyday situation. The team should decide whether it needs one device or several with different indications. Before buying, it is worth visiting a centre that already uses the equipment and asking about sessions per week, failure rates and the wait for service.

A private person with a spinal cord injury. Personal models such as ReWalk Personal, Ekso Indego Personal and Eve are meant to make moving around outside the clinic easier. Manufacturers sell them on prescription after clinical assessment, and the reliable reimbursement information comes from the US. For Poland we have confirmed neither a price nor a sales channel. The safest start is a conversation with the treating doctor and the official distributor, and confirmation of availability should be obtained in writing.

A logistics or manufacturing company. Here one starts with a pilot on a few workstations. According to a Polish source, the logistics operator Dachser is testing exoskeletons in its warehouses rather than rolling them out at scale straight away. That approach is sensible: before buying, you measure donning time, wearing comfort and staff opinion, and an occupational safety specialist does the ergonomic analysis. The article “Humanoid Robots in Factories 2026” shows the wider context of automating physical work in factories.

Why exoskeleton data is often incomplete

In this category manufacturers rarely publish full technical datasheets. Device weight is given for only a few models, while payload, operating time and range of motion are often missing altogether. For medical devices this partly stems from the sales model: clinics get an offer after a conversation, not a price list. We do not treat missing data as a flaw of the product, but as a sign that before buying you must ask the manufacturer for a document and record the answer. If no answer comes, that is a signal too.

Common mistakes

• Buying without analysing the workstation or the patient. An overhead-work exoskeleton is a different design from one for lifting.
• Trusting the manufacturer's video. A demo under an engineer's control is not an ordinary shift.
• Ignoring running costs: sessions, service, training and licences.
• Treating the exoskeleton as a substitute for ergonomics. Occupational safety specialists stress that it complements lifting technique and does not replace it.
• Confusing American and Polish models. Medicare reimbursement does not mean availability in Poland.

How we check the data

We compare every figure with the manufacturer's page or a technical document and record the date and source. Where there is no price, we write "the manufacturer does not publish one". A model gets its own page only when it has enough verified data. We also keep these models apart from similar devices in other categories, such as specialist robots and cobots, so assessments do not get mixed. Explanations of terms such as degrees of freedom are in the “Robotics Glossary: 65 Terms with Polish Equivalents”.